Moukheibir Catherine bought IRWD
June 16, 2026 · Form 4 insider transaction
Moukheibir Catherine bought 63,481 shares of Ironwood Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
63,481
Price
$0.00
Total value
N/A
InsiderMoukheibir Catherine
RoleDirector
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateJune 16, 2026
Filing dateJune 17, 2026
Shares owned after181,425
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.